Toxic acute kidney injury

Friedewald, 2004, Inflammatory cells in ischemic acute renal failure, Kidney Int, 66, 486, 10.1111/j.1523-1755.2004.761_3.x Kelly, 1994, Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury, Proc Natl Acad Sci USA, 91, 812, 10.1073/pnas.91.2.812 Goligorsky, 1993, Pathogenetic role of Arg-Gly-Asp-recognizing integrins in cute renal failure, Proc Natl Acad Sci USA, 90, 5700, 10.1073/pnas.90.12.5700 Noiri, 1994, Cyclic RGD peptides ameliorate ischemic acute renal failure in rats, Kidney Int, 46, 1050, 10.1038/ki.1994.366 Romanov, 1997, Two novel probes reveal tubular and vascular Arg-Gly-Asp (RGD) binding sites in the ischemic rat kidney, Kidney Int, 52, 93, 10.1038/ki.1997.308 Yip, 1997, An Arg-Gly-Asp peptide stimulates constriction in rat afferent arteriole, Am J Physiol, 273, F768 Kootstra, 1997, Effective treatment of experimental lupus nephritis by combined administration of anti-CD11a and anti-CD54 antibodies, Clin Exp Immunol, 108, 324, 10.1046/j.1365-2249.1997.3641266.x Weinberg, 1985, Issues in the pathophysiology of nephrotoxic renal tubular cell injury pertinent to understanding cyclosporine nephrotoxicity, Transplant Proc, 17, 81 Schnellmann, 1999, Pathophysiology of nephrotoxic acute renal failure, 5 Humes, 1988, Aminoglycoside nephrotoxicity, Kidney Int, 33, 900, 10.1038/ki.1988.83 Moore, 1984, Risk factors for nephrotoxicity in patients treated with aminoglycosides, Ann Intern Med, 100, 352, 10.7326/0003-4819-100-3-352 Meyer, 1986, Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides, Am J Med, 80, 119, 10.1016/0002-9343(86)90489-4 Kahlmeter, 1984, Aminoglycoside toxicity: a review of clinical studies published between 1975 and 1982, J Antimicrob Chemother, 13, 9, 10.1093/jac/13.suppl_A.9 Laurent, 1982, Mechanism aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and ami-kacin, Biochem Pharmacol, 31, 3861, 10.1016/0006-2952(82)90303-3 Laurent, 1990, Aminoglycoside-induced renal phospholipidosis and nephrotoxicity, Biochem Pharmacol, 40, 2383, 10.1016/0006-2952(90)90078-Y Kacew, 1990, Pathogenic factors in aminoglycoside induced nephrotoxicity, Toxic ol Lett, 51, 241, 10.1016/0378-4274(90)90067-V Anderson, 1977, Nonoliguric acute renal failure, N Engl J Med, 296, 1134, 10.1056/NEJM197705192962002 Patel, 1979, Symptomatic hypomagnesemia associated with gentamicin therapy, Nephron, 23, 50, 10.1159/000181606 Luft, 1984, Clinical significance of renal changes engendered by aminoglycosides in man, J Antimicrob Chemother, 13, 23, 10.1093/jac/13.suppl_A.23 Schmitz, 2002, Megalin deficiency offers protection from renal aminoglycoside accumulation, J Biol Chem, 277, 618, 10.1074/jbc.M109959200 Silverblatt, 1979, Autoradiography of gentamicin uptake by the rat proximal tubule cell, Kidney Int, 15, 335, 10.1038/ki.1979.45 Silverblatt, 1982, Pathogenesis of nephrotoxicity of cephalosporins and aminoglycosides: a review of current concepts, Rev Infect Dis, 4, S360, 10.1093/clinids/4.Supplement_2.S360 Giuliano, 1984, Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats, Kidney Int, 26, 838, 10.1038/ki.1984.226 Nonclercq, 1992, Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: a time-course study, Ren Fail, 14, 507, 10.3109/08860229209047660 Ngaha, 1983, Studies on gentamicin-induced labialization of rat kidney lysosomes in vitro. Possible protection by selenium, Biochem Pharmacol, 32, 2659, 10.1016/0006-2952(83)90072-2 Regec, 1989, Effect of gentamicin on the lysosomal system of cultured human proximal tubular cells. Endocytotic activity, lysosomal pH and membrane fragility, Biochem Pharmacol, 38, 2527, 10.1016/0006-2952(89)90098-1 Mather, 2001, Polycations induce the release of soluble intermembrane mitochondrial proteins, Biochim Biophys Acta, 1503, 357, 10.1016/S0005-2728(00)00231-0 Morales, 2010, Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway, Kidney Int, 77, 861, 10.1038/ki.2010.11 Walker, 1988, Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats, J C lin Invest, 81, 334, 10.1172/JCI113325 Cuzzocrea, 2002, A role for superoxide in gentamicin-mediated nephropathy in rats, Eur J Pharmacol, 450, 67, 10.1016/S0014-2999(02)01749-1 Branch, 1988, Prevention of Amphotericin B-induced renal impairment. A review on the use of sodium supplementation, Arch Intern Med, 148, 2389, 10.1001/archinte.1988.00380110049010 Sawaya, 1995, Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties, J Am Soc Nephrol, 6, 154, 10.1681/ASN.V62154 Butler, 1964, Nephrotoxicity of Amphotericin B; early and late effects in 81 patients, Ann Intern Med, 61, 175, 10.7326/0003-4819-61-2-175 Harbarth, 2001, The epidemiology of nephrotoxicity associated with conventional Amphotericin B therapy, Am J Med, 111, 528, 10.1016/S0002-9343(01)00928-7 Bates, 2001, Correlates of acute renal failure in patients receiving parenteral Amphotericin B, Kidney Int, 60, 1452, 10.1046/j.1523-1755.2001.00948.x Barton, 1984, Renal magnesium wasting associated with Amphotericin B therapy, Am J Med, 77, 471, 10.1016/0002-9343(84)90106-2 Heidemann, 1983, Amphotericin B nephrotoxicity in humans decreased by salt repletion, Am J Med, 75, 476, 10.1016/0002-9343(83)90353-4 Walsh, 1999, Liposomal Amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group, N Engl J Med, 340, 764, 10.1056/NEJM199903113401004 Fisher, 1989, Risk factors for Amphotericin B-associated nephrotoxicity, Am J Med, 87, 547, 10.1016/S0002-9343(89)80612-6 Zager, 1992, Direct Amphotericin B-mediated tubular toxicity: assessments of selected cytoprotective agents, Kidney Int, 41, 1588, 10.1038/ki.1992.229 Heyman, 1993, Chronic Amphotericin nephropathy: morphometric, electron microscopic, and functional studies, J Am Soc Nephrol, 4, 69, 10.1681/ASN.V4169 Sawaya, 1991, Direct vasoconstriction as a possible cause for Amphotericin B-induced nephrotoxicity in rats, J Clin Invest, 87, 2097, 10.1172/JCI115240 Dórea, 1997, Nephrotoxicity of Amphotericin B is attenuated by solubilizing with lipid emulsion, J Am Soc Nephrol, 8, 1415, 10.1681/ASN.V891415 Luke, 1998, Renal effects of Amphotericin B lipid complex, Am J Kidney Dis, 31, 780, 10.1016/S0272-6386(98)70046-0 Alexander, 2005, Study of renal safety in Amphotericin B lipid complex-treated patients, Clin Infect Dis, 40, S414, 10.1086/429335 White, 1997, Amphotericin B colloidal dispersion vs. Amphotericin B as therapy for invasive aspergillosis, Clin Infect Dis, 24, 635 Wingard, 2000, A randomized, double-blind comparative trial evaluating the safety of liposomal Amphotericin B versus Amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group, Clin Infect Dis, 31, 1155, 10.1086/317451 Sacks, 1987, Recurrent reversible acute renal failure from Amphotericin, Arch Intern Med, 147, 593, 10.1001/archinte.1987.00370030191038 Boulikas, 2003, Cisplatin and platinum drugs at the molecular level. (Review), Oncol Rep, 10, 1663 Litterst, 1977, Plasma levels and organ distribution of platinum in the rat, dog, and dog fish following intravenous administration of cis-DDP (II), J Clin Hematol Oncol, 7, 169 Safirstein, 1984, Uptake and metabolism of cisplatin by rat kidney, Kidney Int, 25, 753, 10.1038/ki.1984.86 Choi, 2008, Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences, Drug Metab Pharmacokinet, 23, 243, 10.2133/dmpk.23.243 Luke, 1992, Role of vascular congestion in cisplatin-induced acute renal failure in the rat, Nephrol Dial Transplant, 7, 1 Winston, 1985, Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat, Am J Physiol, 249, F490 Ramesh, 2002, TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity, J Clin Invest, 110, 835, 10.1172/JCI200215606 Ramesh, 2005, p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice, Am J Physiol Renal Physiol, 289, F166, 10.1152/ajprenal.00401.2004 Kelly, 1999, Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody, Kidney Int, 56, 922, 10.1046/j.1523-1755.1999.00629.x Portilla, 2006, Recent progress in the pathophysiology of acute renal failure, 643 Xu, 2008, Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants, Chem Res Toxicol, 21, 1548, 10.1021/tx800061w Townsend, 2003, Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells, J Am Soc Nephrol, 14, 1, 10.1097/01.ASN.0000042803.28024.92 Baliga, 1999, Oxidant mechanisms in toxic acute renal failure, Drug Metab Rev, 31, 971, 10.1081/DMR-100101947 Davis, 2001, Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide, J Am Soc Nephrol, 12, 2683, 10.1681/ASN.V12122683 Masuda, 1994, Cisplatin generates superoxide anion by interaction with DNA in a cell-free system, Biochem Biophys Res Commun, 203, 1175, 10.1006/bbrc.1994.2306 Tanaka-Kagawa, 1999, Reduced sensitivity of HeLa cells to cisplatinum by simultaneous overexpression of copper, zinc-superoxide dismutase and catalase, Biochem Pharmacol, 57, 545, 10.1016/S0006-2952(98)00328-1 Rose, 2001, 120 Kim, 2001, Cisplatin decreases the abundance of aquaporin water channels in rat kidney, J Am Soc Nephrol, 12, 875, 10.1681/ASN.V125875 Ciarimboli, 2005, Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2, Am J Pathol, 167, 1477, 10.1016/S0002-9440(10)61234-5 Hansen, 1988, Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer, J Clin Oncol, 6, 1728, 10.1200/JCO.1988.6.11.1728 Brock, 1991, Partial reversibility of cisplatin nephrotoxicity in children, J Pediatr, 118, 531, 10.1016/S0022-3476(05)83372-4 Georgaki-Angelaki, 1989, Renal function following acute renal failure in childhood: a long term follow-up study, Kidney Int, 35, 84, 10.1038/ki.1989.11 Brenner, 1985, Nephron adaptation to renal injury or ablation, Am J Physiol, 249, F324